Akebia Therapeutics, Inc.

AKBA·NASDAQ·$1.04Share Price as of 11/2·$279MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/23/26 8-KCurrent report10/14/26 8-KCurrent report08/05/26 8-KCurrent report06/30/26 8-KCurrent report06/22/26

Prospectuses and Registrations

S-8Registration of securities for employees08/05/26 S-8Registration of securities for employees08/07/25 424B5Prospectus supplement03/20/25 424B5Prospectus supplement03/19/25 S-8Registration of securities for employees01/30/25

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 PRE 14APreliminary proxy04/15/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25

Ownership

Form 4Insider transaction08/10/26 Form 4Insider transaction07/01/26 144Proposed sale of securities06/29/26 Form 4Insider transaction06/22/26 Form 4Insider transaction06/22/26

Other

ARSAnnual report to shareholders04/29/26 ARSAnnual report to shareholders04/29/25 EFFECTRequest for effectiveness09/12/24 CORRESPCorrespondence with the SEC09/10/24 UPLOADLetter from the SEC09/09/24